Replies to post #104 on Remedent, Inc. (REMI)

[garp0]

re: Biotech's interest: clarification appreciated.
Initiated as a strategy for client retention, and though
not generating meaningful cash flow, there is a possibility
it could evolve into an additional revenue stream.
i read recently (while waiting for my dentist), the dental implant business
in the BRICs is experiencing rapid growth, and China
most particularly, the strongest, least competitive, most generous margins.
It's going to be big someday. i think offering it enhances the image
of Glamsmile.

i see my purchases of REMI as furthering
illiquidity since i don't trade the stock, nor can i